TollereBio Overview
- Industry
- Biotechnology Research
- Employees
- 3
- Founded
- 2023
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About TollereBio
TollereBio was founded to commercialize the BECC Technology planform for adjuvant development invented by Dr. Robert K. Ernst at the University of Maryland, Baltimore. The BECC platform enables quick and efficient engineering of lipid A mimetics for identification of new TLR4 adjuvants with customized immunostimulatory properties. Our team of experienced industry veterans is excited to offer accessible, cost-effective vaccine adjuvants that can have a positive impact on global human health.
TollereBio Contact Details
- People in AeroLeads
- 3
- With contact data
- 2
- Email contacts
- 2
- 66.7% coverage
- Phone contacts
- 2
- 66.7% coverage
TollereBio Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Charles Richardson | Bozeman, Montana, United States |
Email
Phone
|
|
| Bob Ernst | Professor and Chair | Baltimore City County, Maryland, United States |
Email
Phone
|
| Hans Lien | Co-founder & COO at Tollerebio |
View
|
Compare Similar Companies to TollereBio
NantBio
Biotechnology
Abwiz Bio Inc
Biotechnology Research
ARYTE Bioscience, LLC
Biotechnology Research
Open Problems in Single-Cell Analysis
Biotechnology Research
Cogenesis, Inc.
Biotechnology Research
Tidewave Bio
Biotechnology Research
Pataigin
Biotechnology Research
Escalier Biosciences B.V.
Biotechnology Research
ImmuneCyte, Inc.
Biotechnology
TargetRNA Inc.
Pharmaceutical Manufacturing